Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

August 17, 2020

Sirtex Medical Partners With Magle Chemoswed to Develop Imaging Agent

August 17, 2020—Sirtex Medical US Holdings, Inc. announced a collaboration with Magle Chemoswed, a Sweden-based contract development and manufacturing organization.

The development and commercial agreement grants Sirtex global use of Magle Chemoswed’s technology to develop a novel imaging agent for use in interventional oncology. Sirtex will have the exclusive license and commercialization rights in the defined field of use. Magle Chemoswed maintains rights to its technology platform and to exclusively manufacture the product for supply to Sirtex. The development program will begin in Q3 2020.

Advertisement

August 17, 2020

Postmarket PATHFINDER I Registry Commences for AngioDynamics’ Auryon Atherectomy System

left-arrow Created with Sketch. Previous Article

August 17, 2020

FDA Approves IDE for Pivotal TRIOMPHE Study of Endospan’s Nexus Aortic Arch Stent Graft System

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)